SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006373
Filing Date
2017-08-09
Accepted
2017-08-09 12:33:22
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ecyt-20170630x10q.htm 10-Q 1327646
2 EX-10.1 ecyt-20170630ex101acb552.htm EX-10.1 1645136
3 EX-10.2 ecyt-20170630ex102946a2c.htm EX-10.2 190402
4 EX-31.1 ecyt-20170630ex31149d190.htm EX-31.1 19957
5 EX-31.2 ecyt-20170630ex312a43187.htm EX-31.2 18040
6 EX-32.1 ecyt-20170630ex321142341.htm EX-32.1 15453
  Complete submission text file 0001558370-17-006373.txt   7111752

Data Files

Seq Description Document Type Size
7 EX-101.INS ecyt-20170630.xml EX-101.INS 1265595
8 EX-101.SCH ecyt-20170630.xsd EX-101.SCH 25718
9 EX-101.CAL ecyt-20170630_cal.xml EX-101.CAL 29997
10 EX-101.DEF ecyt-20170630_def.xml EX-101.DEF 113880
11 EX-101.LAB ecyt-20170630_lab.xml EX-101.LAB 286720
12 EX-101.PRE ecyt-20170630_pre.xml EX-101.PRE 233365
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 171017103
SIC: 2834 Pharmaceutical Preparations